Develops medical devices for cardiovascular diseases.
Jun 2026Revenue $80.2M/yrExpenses $81.8M/yr
No trend
Figures by year
When will VASO be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $80.2M and expenses $81.8M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $89.1M | $92.0M | −$2.89M |
| Dec 2024 | $86.8M | $86.5M | $285K |
| Dec 2023 | $81.0M | $76.8M | $4.20M |
| Dec 2022 | $79.3M | $72.8M | $6.45M |
| Dec 2021 | $75.6M | $72.8M | $2.82M |
| Dec 2020 | $69.8M | $69.1M | $772K |
| Dec 2019 | $75.5M | $74.9M | $591K |
| Dec 2018 | $74.0M | $77.7M | −$3.72M |
| Dec 2017 | $72.8M | $76.6M | −$3.83M |
| Dec 2016 | $72.6M | $71.0M | $1.56M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.